List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #40,371 to #40,420.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. PPD skin testMantoux test
  2. PPD testMantoux test
  3. PPEPalmar plantar erythrodysesthesia
  4. PPGSSPapular purpuric gloves and socks syndrome
  5. PPHPulmonary hypertension
  6. PPIProton pump inhibitor
  7. PPMArtificial pacemaker
  8. PPM infectionNonvalvular cardiovascular device-related infections
  9. PPPPrimary Prevention Project
  10. PPTPostpartum thyroiditis
  11. PPVPositive predictive value
  12. PPomaNeuroendocrine tumors
  13. PQRSTProbucol Quantitative Regression Swedish Trial
  14. PRACTICALComparison Of Enalapril Versus Captopril On Left Ventricular Function And Survival Three Months After Acute Myocardial Infarction
  15. PRAGUEPrimary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis
  16. PRAGUE-8Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis-8
  17. PRAISEProspective Randomized Amlopidine Survival Evaluation
  18. PRAISE-1Prospective Randomized Amlodipine Survival Evaluation-1
  19. PRAISE-2Prospective Randomized Amlodipine Survival Evaluation-2
  20. PREAMIPerindopril Remodeling In Elderly With Acute Myocardial Infarction
  21. PRECISEDouble-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
  22. PREDICTEffect Of Pravastatin On Angiographic Restenosis After Coronary Balloon Angioplasty
  23. PREMIARProtection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
  24. PREMIEREffects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
  25. PREPAIRClopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens
  26. PREPARE — Presented at TCT 2008Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation
  27. PREPICA Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
  28. PRESENTPreliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
  29. PRESERVEProspective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
  30. PRESTOResults Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
  31. PREVEND ITPrevention Of Renal And Vascular End-Stage Disease Intervention Trial
  32. PREVENT(Radiation)Proliferation Reduction With Vascular Energy Trial
  33. PREVENT (Dalteparin)Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
  34. PREVENT (Warfarin)Venous thromboembolism
  35. PREVENT IIThe Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg
  36. PREVENT IVProject Of Ex-Vivo Vein Graft Engineering Via Transfection
  37. PRF1Perforin
  38. PRIDEA Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
  39. PRIMA — Presented at ACC.09/i2Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
  40. PRIME-2Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
  41. PRIMIPro-Urokinase For Myocardial Infarction
  42. PRIMO-CABGPexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
  43. PRIMO-CABG IIPexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
  44. PRINCEEffect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
  45. PRINCESSPrevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
  46. PRINCIPLE-TIMI 44The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
  47. PRISMPlatelet-Receptor Inhibition For Ischemic Syndrome Management
  48. PRISM-PLUSPlatelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
  49. PRISM-TroponinTroponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
  50. PRISON IIProspective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions

View ( | ) (20 | 50 | 100 | 250 | 500)